Literature DB >> 11802803

A statistical study of lung cancer in the annual of pathological autopsy cases in Japan, from 1958 to 1997, with reference to time trends of lung cancer in the world.

Toyohiko Morita1.   

Abstract

Lung cancer cases (66650 males and 20890 females) registered in the Annual of Pathological Autopsy Cases in Japan, between 1958 and 1997, were analyzed with regard to sex, age and histology. They were subdivided into decades (periods I to IV), and compared with the Japanese mortality statistics, with which they were in good correspondence. Although the autopsy rate is decreasing, more than 10% of the total lung cancer deaths in Japan were registered by 1990. Among autopsied cases, the incidence of lung cancer cases increased from 6% to 12% in males and from 3% to 6% in females. From period III, lung cancer in males became the most frequent, and was the second most frequent cancer in females after gastric cancer. As for the histological distribution, adenocarcinoma was the most frequent and squamous cell carcinoma was the next most frequent in both sexes. Recently, a significant increase in adenocarcinoma and a significant decrease in squamous cell carcinoma have been observed in both sexes. The peak ages shifted from the 60s to the 70s and a significant rise in the mean ages were observed. The male-to-female ratios and the ratio curves by histological and age group were high for squamous cell carcinoma and small cell carcinoma, while they were low for the total and adenocarcinoma. With the recently acquired data on lung cancer in Asian countries, and from the male-to-female ratios and the status of smoking rates, lung cancer in the world at present was divided into three groups; North America, Europe and Asia. The possibility of one group changing to resemble another and of groups converging in the near future is suggested.

Entities:  

Mesh:

Year:  2002        PMID: 11802803      PMCID: PMC5926863          DOI: 10.1111/j.1349-7006.2002.tb01195.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  23 in total

1.  A statistical analysis of lung cancer registered in the Annual of Pathological Autopsy Cases in Japan between 1958 and 1987, with special reference to the characteristics of lung cancer in Japan.

Authors:  T Morita; H Sugano
Journal:  Acta Pathol Jpn       Date:  1990-09

2.  The autopsy and vital statistics.

Authors:  T Kircher
Journal:  Hum Pathol       Date:  1990-02       Impact factor: 3.466

3.  The trends in histological types of lung cancer during 1980-1988, Guangzhou, China.

Authors:  Q Cha; Y Chen; Y Du
Journal:  Lung Cancer       Date:  1997-07       Impact factor: 5.705

4.  Trend of lung cancers in the National Cancer Center of Japan and comparison with that of Japanese pathological autopsy records.

Authors:  S Watanabe; S Tsugane; H Arimoto; Y Shimosato; K Suemasu; H Arai; Y Urano
Journal:  Jpn J Cancer Res       Date:  1987-05

5.  International differences in epidemiology of lung adenocarcinoma.

Authors:  A Charloux; M Rossignol; A Purohit; D Small; N Wolkove; G Pauli; E Quoix; H Kreisman
Journal:  Lung Cancer       Date:  1997-03       Impact factor: 5.705

6.  Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking.

Authors:  S D Stellman; J E Muscat; S Thompson; D Hoffmann; E L Wynder
Journal:  Cancer       Date:  1997-08-01       Impact factor: 6.860

7.  Cigarette smoking and changes in the histopathology of lung cancer.

Authors:  M J Thun; C A Lally; J T Flannery; E E Calle; W D Flanders; C W Heath
Journal:  J Natl Cancer Inst       Date:  1997-11-05       Impact factor: 13.506

8.  Differences in lung cancer risk between men and women: examination of the evidence.

Authors:  E A Zang; E L Wynder
Journal:  J Natl Cancer Inst       Date:  1996-02-21       Impact factor: 13.506

9.  Changing trends in histologic types of lung cancer during the last decade (1981-1990) in Korea: a hospital-based study.

Authors:  J H Choi; H C Chung; N C Yoo; H R Lee; K H Lee; W Choi; H Y Lim; E H Koh; J H Kim; J K Roh
Journal:  Lung Cancer       Date:  1994-03       Impact factor: 5.705

10.  Epidemiological studies on lung cancer in the Bohemia region.

Authors:  M Marel; P Kalina; T Melínová; J Krenarová; J Lutzbauerová; Z Rehorová
Journal:  Lung Cancer       Date:  1994-03       Impact factor: 5.705

View more
  18 in total

1.  Phase II study of Amrubicin monotherapy in elderly or poor-risk patients with extensive disease of small cell lung cancer.

Authors:  Satoshi Igawa; Sakiko Otani; Shinichiro Ryuge; Tomoya Fukui; Yoshiro Nakahara; Yasuhiro Hiyoshi; Mikiko Ishihara; Seiichiro Kusuhara; Shinya Harada; Hisashi Mitsufuji; Masaru Kubota; Jiichiro Sasaki; Noriyuki Masuda
Journal:  Invest New Drugs       Date:  2017-06-20       Impact factor: 3.850

2.  Amrubicin for treating elderly and poor-risk patients with small-cell lung cancer.

Authors:  Satoshi Igawa; Shinichiro Ryuge; Tomoya Fukui; Sakiko Otani; Yuka Kimura; Ken Katono; Akira Takakura; Masaru Kubota; Hisashi Mitsufuji; Masato Katagiri; Nobuo Yanase; Noriyuki Masuda
Journal:  Int J Clin Oncol       Date:  2010-05-13       Impact factor: 3.402

3.  Lung cancer occurrence in Southern Iran.

Authors:  Mohammad Javad Tarrahi; Davood Mehrabani; Farnaz Khademolhosseini; Masoud Amini; Seyed Jalil Masoumi; Hasan Julaee; Mahin Farahmand
Journal:  J Res Med Sci       Date:  2009-03       Impact factor: 1.852

4.  Prognostic model of stage II non-small cell lung cancer by a discriminant analysis of the immunohistochemical protein expression.

Authors:  Takayuki Kohri; Masayuki Sugano; Osamu Kawashima; Ryusei Saito; Shinji Sakurai; Takaaki Sano; Takashi Nakajima
Journal:  Surg Today       Date:  2006-12-25       Impact factor: 2.549

5.  The development and validation of a prediction tool for chemotherapy-induced anemia in patients with advanced nonsmall cell lung cancer receiving palliative chemotherapy.

Authors:  Mark Vincent; George Dranitsaris; Sunil Verma; Cathy Lau; Pere Gascon; Simon Van Belle; Heinz Ludwig
Journal:  Support Care Cancer       Date:  2006-11-21       Impact factor: 3.603

Review 6.  Worldwide trend of increasing primary adenocarcinoma of the lung.

Authors:  Haruhiko Nakamura; Hisashi Saji
Journal:  Surg Today       Date:  2013-06-11       Impact factor: 2.549

7.  Induction and persistence of radiation-induced DNA damage is more pronounced in young animals than in old animals.

Authors:  Darryl Hudson; Igor Kovalchuk; Igor Koturbash; Bryan Kolb; Olga A Martin; Olga Kovalchuk
Journal:  Aging (Albany NY)       Date:  2011-06       Impact factor: 5.682

8.  Changes in the demographics and prognoses of patients with resected non-small cell lung cancer: a 20-year experience at a single institution in Korea.

Authors:  Jin Gu Lee; Chang Young Lee; Mi Kyung Bae; Chun Sung Byun; Dae Joon Kim; Kyung Young Chung
Journal:  J Korean Med Sci       Date:  2012-12-07       Impact factor: 2.153

9.  Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702.

Authors:  H Okamoto; K Watanabe; H Kunikane; A Yokoyama; S Kudoh; T Asakawa; T Shibata; H Kunitoh; T Tamura; N Saijo
Journal:  Br J Cancer       Date:  2007-06-19       Impact factor: 7.640

10.  Sex-differences in lung cancer cell-types? An epidemiologic study in Ireland.

Authors:  Zubair Kabir; Gregory N Connolly; Luke Clancy
Journal:  Ulster Med J       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.